Short answers, llms files and markdown copies
The most-read pages open with a dated short answer computed from the data where the answer is a figure. /llms.txt was rebuilt, /llms-full.txt added, and every page has a markdown copy at its path plus .md. Every page shows the date it was last updated.
City pages consolidated
Forty-five compound-by-district pages were folded into their city hubs, each of which now carries a short, dataset-built note per compound. Ten compound pages with no published evidence to cite were set to noindex until sources exist.
Compound pages rebuilt on the research data
Every compound page now shows benefits studied with an evidence level per finding, side effects reported next to them, trial results and regulatory status, from the Research Desk datasets published by our partner and supplier. Dosing tables and outcome timelines were removed. Seven retatrutide topic pages were merged into the retatrutide page.
Telehealth tracker
Seven Philippine GLP-1 telehealth and clinic programs, with what each price includes and whether medication is in it, read from each program’s own pages. Profiles of GoRocky and &you.
Regulation hub
What RA 9711 and FDA Philippines say about peptides and GLP-1 medicines: registration, prescriptions, bringing medicines in, selling, the advisory timeline and status by compound, from primary sources.
GLP-1 price tracker
Dated prices for Ozempic, Wegovy, Mounjaro, Rybelsus and Saxenda at Philippine pharmacies and clinics, each row linked to the page it was read from, with FDA Philippines registration numbers. Downloadable as JSON and CSV.
Seller comparisons removed
The supplier comparison page and every metric naming another peptide seller were removed.
Changelog
Changelog
What changed on this site and when: new data, rebuilt pages, retired pages and corrected facts, newest first.